The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Testicular Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Testicular Neoplasms


Psychiatry related information on Testicular Neoplasms


High impact information on Testicular Neoplasms


Chemical compound and disease context of Testicular Neoplasms


Biological context of Testicular Neoplasms


Anatomical context of Testicular Neoplasms


Gene context of Testicular Neoplasms


Analytical, diagnostic and therapeutic context of Testicular Neoplasms


  1. Males exposed in utero to diethylstilbestrol. Leary, F.J., Resseguie, L.J., Kurland, L.T., O'Brien, P.C., Emslander, R.F., Noller, K.L. JAMA (1984) [Pubmed]
  2. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Chiriva-Internati, M., Wang, Z., Salati, E., Bumm, K., Barlogie, B., Lim, S.H. Blood (2002) [Pubmed]
  3. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Ylikorkala, A., Avizienyte, E., Tomlinson, I.P., Tiainen, M., Roth, S., Loukola, A., Hemminki, A., Johansson, M., Sistonen, P., Markie, D., Neale, K., Phillips, R., Zauber, P., Twama, T., Sampson, J., Järvinen, H., Mäkelä, T.P., Aaltonen, L.A. Hum. Mol. Genet. (1999) [Pubmed]
  4. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Fumo, G., Akin, C., Metcalfe, D.D., Neckers, L. Blood (2004) [Pubmed]
  5. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. Nuver, J., Smit, A.J., van der Meer, J., van den Berg, M.P., van der Graaf, W.T., Meinardi, M.T., Sleijfer, D.T., Hoekstra, H.J., van Gessel, A.I., van Roon, A.M., Gietema, J.A. J. Clin. Oncol. (2005) [Pubmed]
  6. Lithium pharmacokinetics during cisplatin-based chemotherapy: a case report. Beijnen, J.H., Bais, E.M., ten Bokkel Huinink, W.W. Cancer Chemother. Pharmacol. (1994) [Pubmed]
  7. The role of radioimmunodetection in the management of testicular cancer. Javadpour, N., Kim, E.E., DeLand, F.H., Salyer, J.R., Shah, U., Goldenberg, D.M. JAMA (1981) [Pubmed]
  8. Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy. Samuels, M.L., Johnson, D.E., Holoye, P.Y., Lanzotti, V.J. JAMA (1976) [Pubmed]
  9. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. Jäger, E., Jäger, D., Karbach, J., Chen, Y.T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L.J., Knuth, A. J. Exp. Med. (2000) [Pubmed]
  10. Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting. Dutoit, V., Taub, R.N., Papadopoulos, K.P., Talbot, S., Keohan, M.L., Brehm, M., Gnjatic, S., Harris, P.E., Bisikirska, B., Guillaume, P., Cerottini, J.C., Hesdorffer, C.S., Old, L.J., Valmori, D. J. Clin. Invest. (2002) [Pubmed]
  11. Treatment-associated leukemia following testicular cancer. Travis, L.B., Andersson, M., Gospodarowicz, M., van Leeuwen, F.E., Bergfeldt, K., Lynch, C.F., Curtis, R.E., Kohler, B.A., Wiklund, T., Storm, H., Holowaty, E., Hall, P., Pukkala, E., Sleijfer, D.T., Clarke, E.A., Boice, J.D., Stovall, M., Gilbert, E. J. Natl. Cancer Inst. (2000) [Pubmed]
  12. Estrogen exposure during gestation and risk of testicular cancer. Depue, R.H., Pike, M.C., Henderson, B.E. J. Natl. Cancer Inst. (1983) [Pubmed]
  13. Test of false-positive testicular cancer marker by suppressing luteinizing hormone with testosterone. Phillips, M.I., Weiner, R., MacLaren, N., Kappy, M. Lancet (1982) [Pubmed]
  14. Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer. Fosså, S.D., Poulsen, J.P., Aaserud, A. Lancet (1992) [Pubmed]
  15. Dimethylformamide, metal dyes, and testicular cancer. Ducatman, A.M. Lancet (1989) [Pubmed]
  16. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller, T., Voigt, W., Simon, H., Fruehauf, A., Bulankin, A., Grothey, A., Schmoll, H.J. Cancer Res. (2003) [Pubmed]
  17. Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor. Hatakeyama, S., Ohyama, C., Minagawa, S., Inoue, T., Kakinuma, H., Kyan, A., Arai, Y., Suga, T., Nakayama, J., Kato, T., Habuchi, T., Fukuda, M.N. Cancer Res. (2004) [Pubmed]
  18. Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one family. Teh, B.T., Linblad, K., Nord, B., Kytölä, S., Schalling, M., Larsson, C., Rapley, E., Biggs, P., Huddart, R., Stratton, M. J. Med. Genet. (1999) [Pubmed]
  19. Occupational exposure to polyvinyl chloride as a risk factor for testicular cancer evaluated in a case-control study. Hardell, L., Ohlson, C.G., Fredrikson, M. Int. J. Cancer (1997) [Pubmed]
  20. Genotype and phenotype of glutathione S-transferase mu in testicular cancer patients. Vistisen, K., Priemé, H., Okkels, H., Vallentin, S., Loft, S., Olsen, J.H., Poulsen, H.E. Pharmacogenetics (1997) [Pubmed]
  21. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Vogelzang, N.J., Bosl, G.J., Johnson, K., Kennedy, B.J. Ann. Intern. Med. (1981) [Pubmed]
  22. Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Chen, Y.T., Scanlan, M.J., Venditti, C.A., Chua, R., Theiler, G., Stevenson, B.J., Iseli, C., Gure, A.O., Vasicek, T., Strausberg, R.L., Jongeneel, C.V., Old, L.J., Simpson, A.J. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  23. POTE paralogs are induced and differentially expressed in many cancers. Bera, T.K., Saint Fleur, A., Lee, Y., Kydd, A., Hahn, Y., Popescu, N.C., Zimonjic, D.B., Lee, B., Pastan, I. Cancer Res. (2006) [Pubmed]
  24. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. Siegert, W., Beyer, J., Strohscheer, I., Baurmann, H., Oettle, H., Zingsem, J., Zimmermann, R., Bokemeyer, C., Schmoll, H.J., Huhn, D. J. Clin. Oncol. (1994) [Pubmed]
  25. Fertility after chemotherapy for testicular cancer. Drasga, R.E., Einhorn, L.H., Williams, S.D., Patel, D.N., Stevens, E.E. J. Clin. Oncol. (1983) [Pubmed]
  26. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Scanlan, M.J., Welt, S., Gordon, C.M., Chen, Y.T., Gure, A.O., Stockert, E., Jungbluth, A.A., Ritter, G., Jäger, D., Jäger, E., Knuth, A., Old, L.J. Cancer Res. (2002) [Pubmed]
  27. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Vatolin, S., Abdullaev, Z., Pack, S.D., Flanagan, P.T., Custer, M., Loukinov, D.I., Pugacheva, E., Hong, J.A., Morse, H., Schrump, D.S., Risinger, J.I., Barrett, J.C., Lobanenkov, V.V. Cancer Res. (2005) [Pubmed]
  28. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Robertson, K.A., Bullock, H.A., Xu, Y., Tritt, R., Zimmerman, E., Ulbright, T.M., Foster, R.S., Einhorn, L.H., Kelley, M.R. Cancer Res. (2001) [Pubmed]
  29. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice. Cheo, D.L., Burns, D.K., Meira, L.B., Houle, J.F., Friedberg, E.C. Cancer Res. (1999) [Pubmed]
  30. Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer. Smith-Sørensen, B., Lind, G.E., Skotheim, R.I., Fosså, S.D., Fodstad, Ø., Stenwig, A.E., Jakobsen, K.S., Lothe, R.A. Oncogene (2002) [Pubmed]
  31. Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy. Hansen, P.V., Trykker, H., Helkjoer, P.E., Andersen, J. J. Natl. Cancer Inst. (1989) [Pubmed]
  32. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Wang, Z., Zhang, Y., Liu, H., Salati, E., Chiriva-Internati, M., Lim, S.H. Blood (2003) [Pubmed]
  33. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Guo, Z.S., Hong, J.A., Irvine, K.R., Chen, G.A., Spiess, P.J., Liu, Y., Zeng, G., Wunderlich, J.R., Nguyen, D.M., Restifo, N.P., Schrump, D.S. Cancer Res. (2006) [Pubmed]
  34. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Yin, Y.H., Li, Y.Y., Qiao, H., Wang, H.C., Yang, X.A., Zhang, H.G., Pang, X.W., Zhang, Y., Chen, W.F. Br. J. Cancer (2005) [Pubmed]
  35. The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna. Bokemeyer, C., Schmoll, H.J., Ludwig, E., Harstrick, A., Dunn, T., Casper, J. Br. J. Cancer (1994) [Pubmed]
WikiGenes - Universities